Martini B: [Lung cancer--epidemiology, prognosis and therapy]. Med Monatsschr Pharm. 2006, 29 (6): 217-21.
Zou T, Liu JY, She L, Yin JY, Li X, Li XP, Zhou HH, Chen J, Liu ZQ: The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Front Pharmacol. 2020, 11 (): 1029.
Li L, Zhou Q, Luo D, Xu Y, Yang H, Zhang S, Li A, Li H, Lv C: [A study on the relationship between lung cancer cell apoptosis and prognosis in patients with human non-small cell lung cancer.]. Zhongguo Fei Ai Za Zhi. 1998, 1 (2): 70-3.
Feng YY, Yang Y, Wang YY, Bai XX, Hai P, Zhao R: [Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. Zhonghua Zhong Liu Za Zhi. 2021, 43 (12): 1264-1268.
Xiao Y, Zhu S, Yin W, Liu X, Hu Y: IGFBP-4 expression is adversely associated with lung cancer prognosis. Oncol Lett. 2017, 14 (6): 6876-6880.
Lang J, Zhao Q, He Y, Yu X: Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018, 23 (6): 518-526.
['Atassalang: medis']
["Iyyae situs web e ripassedia untu' akkatta-akkatta pendidikan nenniya informasi bawang na de'na mabbere saran medis iyarega layanan profesional."]
["Rilaleng iyyae, jaringang saraf iya makkewassele bali lao ri pakkutanae, de'na coco narekko engka assisompungenna sibawa angke. contona, egana tau iya riruntue sibawa lasa mattentu."]
["Tuli sappai pangajana doktere'mu iyarega pajjama kesehatang laingnge iyya engkae kualifikasi'e ri tujunna keadaang medis'e. Aja' naengka muwallupai pangajana doktere' iyarega matengnge ri laleng sappa'na nasaba engka aga pura mubaca ri situs web'e. Narekko muwasengngi engka passaleng medis iya parellu'e ripassappa, mobbii 911 iyarega lao ri ruang darurat kaminang macawe'e masitta'. De gaga assisompungeng doktere-pasien iyya ripancaji pole situs web'e iyarega akkegunanna. BioMedLib iyarega pajjamana, iyarega muwi niga pattarima lao ri situs web'e, de nawerengngi aga-aga, manessa iyarega tersirat, ri tujunna kareba iyya riyabbere'e iyarega akkegunanna."]
['Disclaimer: hak cipta']
["Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) mabbere daya tarik lao ri punnana hak cipta iya mateppe'e majeppuu agaaga iya engkae ri Internet naruntu'i hakna ri yawa hukung hak cipta AS. "]
["Narekko mateppe'ko sibawa makessing majeppuu agaaga lise'na iyarega agaaga iya engkae ri laleng situs web iyarega jasae naruntu'i hak cipta'mu, iko (iyarega agenna) wedding kiringki pappaseng iyya naeloriwi lise' iyarega agaaga ripassu, iyarega akses lao ri iyyae ritongkoi."]
["DMCA parellu i nawereng pappaseng mu ri palanggarang hak cipta nawereng i pappaseng iyyae: (1) pappaseng pole ri jama-jamang hak cipta iyyae mancaji pakkitanna palanggarang iya nawereng i; (2) pappaseng pole ri konten iya nawereng i nenniya pappaseng iya genne'e untu' nawereng i onrong konten e; (3) pappaseng assisumpungemmu, matame' alamat, nomoro' telepon, nenniya alamat emailmu; (4) pappaseng pole ri iko makkedae iko mateppe'i majeppu konten iya engkae rilalenna pappaseng iyya mu nawereng i de'na ripalaloi pole ri punnana hak cipta, iyarega agen na, iyarega pole ri hukum e; "]
["(5) seddi pappaseng pole ri iko, ritanrai ri yawa pahukkungeng sabbi bellé, makkeda kareba ri laleng pappasengnge coco'i sibawa iko mappunnaiwi otoritas untu' napake hak cipta iya rituntut pura rikalang;"]
["nenniya (6) tanrang lima fisik iyarega elektronik pole punnana hak cipta iyarega tau iya ripalalo e untu' majjama ri laleng asenna punnana hak cipta e. "]
The prognosis of lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the overall health of the patient.
Non-small cell lung cancer, which is the most common type, has a 5-year survival rate of about 18% for all stages combined.
However, if the cancer is caught early, the 5-year survival rate can be as high as 57%. Small cell lung cancer, which is less common, has a 5-year survival rate of about 7% for all stages combined.
It is important to note that these are general statistics and individual outcomes may vary.
Treatment options and advancements in medicine continue to improve, and many patients can live longer and have a better quality of life with proper care and management.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
